JPRN-UMIN000015180已完成未知
The clinical study of the safety and efficacy of denosumab for glucocorticoid-induced osteoporosis - The clinical study of the safety and efficacy of denosumab for glucocorticoid-induced osteoporosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 56
研究概览
简要总结
Denosumab significantly increased the mean BMD of the lumbar spine and bilateral hip (5.8%, and 1.3%, respectively).
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with hypocalcemia
研究者
相似试验
已完成
3 期
Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced OsteoporosisEvaluate the Safety and Efficacy of Denosumab in Pediatric Subjects WithGlucocorticoid-induced OsteoporosisNCT03164928Amgen24
Unknown
4 期
Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar FusionFusion of Spine, Lumbar RegionOsteoporosisNCT05203588Shanghai Changzheng Hospital116
Unknown
不适用
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for JapaneseOsteoporosisNCT02166437Tomidahama Hospital500
已完成
3 期
Denosumab for Prevention of Osteoporosis in Renal Transplant RecipientsOsteoporosisChronic Kidney DiseaseNCT01377467Rudolf Wuethrich90
已完成
2 期
Effects of Denosumab on Periprosthetic Bone After Total Hip ArthroplastyOsteoarthritis, HipAmbulation DifficultyNCT01630941Hans Mallmin64